Vimarsana
Biggest News Aggregation in the World

Page 43 - Linical Studies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Linical Studies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Linical Studies Today - Breaking & Trending Today

Diabetes Drug Class Appears to Reduce Recurrent Gout Flares - Vimarsana News

Diabetes Drug Class Appears to Reduce Recurrent Gout Flares

Previously associated with a lower incidence of gout, sodium-glucose cotransporter-2 (SGLT2) inhibitors for the first time also appear to reduce gout flare recurrence and excess mortality.

Tralokinumab Safe, Effective in Older Pop With AD: Analysis - Vimarsana News

Tralokinumab Safe, Effective in Older Pop With AD: Analysis

The findings are important for the older patient population who "typically face unique treatment challenges," the authors write.

Impact of RV Pacing in HF, CRT Benefit Shown in BUDAPEST-CRT - Vimarsana News

Impact of RV Pacing in HF, CRT Benefit Shown in BUDAPEST-CRT

'This is a population that has not gotten a lot of attention,' said an expert. Upgrading their pacemakers to a cardiac resynchronization device may be the answer for some.

Screening Finds High Rates of CVD in Diabetes, COPD Patients - Vimarsana News

Screening Finds High Rates of CVD in Diabetes, COPD Patients

A systematic approach to cardiovascular disease screening in adults with type 2 diabetes, COPD, or both led to more than doubling the rate of new CVD cases found compared with usual care.

Industry Funding for Rheumatology Research Falls - Vimarsana News

Industry Funding for Rheumatology Research Falls

Research-associated payments dipped by 24% from 2014 to 2022, new data suggest.